(Q36080935)

12 August 2017

Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer (English)

1 reference

12 August 2017

Jørgensen T

1

1 reference

12 August 2017

Yogesan K

2

1 reference

12 August 2017

Skjørten F

3

1 reference

12 August 2017

Berner A

4

1 reference

12 August 2017

Tveter KJ

5

1 reference

12 August 2017

Danielsen HE

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

71

1 reference

12 August 2017

5

1 reference

12 August 2017

1055-1060

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.203

12 August 2017

0 references

cites work

New prognostic factors in prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Spread of prostatic cancer to bone

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Measuring repeatability and validity of histological diagnosis--a brief review with some practical examples

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Proceedings: The natural history of prostatic cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Flow cytometry and prognostic implications in patients with solid tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Ploidy level and tumor progression in prostatic carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Histologic grading of prostate cancer: a perspective

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Management of relapsing disease in prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

The Measurement of Observer Agreement for Categorical Data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

DNA as a prognostic marker in advanced high-grade prostatic cancer. A preliminary report. SPCG-I study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Modal DNA-values in prostate cancer patients with deferred therapy or endocrine therapy.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Problems of grading carcinoma of prostate

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033801

Correlation between ploidy and prognosis in prostatic carcinoma

23 September 2018

1 reference

12 December 2020

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

12 December 2020

Prognostic significance of nuclear DNA levels in prostatic carcinoma

1 reference

12 December 2020

Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy

1 reference

12 December 2020

Total androgen suppression: experience from the Scandinavian Prostatic Cancer Group Study No. 2

1 reference

12 December 2020

Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer

1 reference

12 December 2020

Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence

1 reference

12 December 2020

Histological evaluation of prostatic cancer. (II): Reproducibility of a histological grading system

1 reference

12 December 2020

Analysis of prognostic factors in disseminated prostatic cancer. An update. Dutch Southeastern Urological Cooperative Group

1 reference

12 December 2020

Prognostic significance of the nuclear DNA content in localized prostatic adenocarcinoma

1 reference

12 December 2020

Development of Prostatic Carcinoma: Morphometric and pathologic features of early stages

1 reference

12 December 2020

The prognostic value of deoxyribonucleic acid flow cytometric analysis in stage D2 prostatic carcinoma

1 reference

12 December 2020

Analysis of prognostic factors in men with metastatic prostate cancer. Uro-Oncology Group of Northern Alberta

1 reference

12 December 2020

The prognostic significance of nuclear DNA content in prostatic carcinoma

1 reference

12 December 2020

DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas

1 reference

12 December 2020

Orchiectomy for advanced prostatic carcinoma A reevaluation

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.203

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

7734299

1 reference